Jean-Ehrland Ricci

15PUBLICATIONS
39CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 16, 2026
PINK1-mediated mitophagy supports lung cancer initiation and limits the efficacy of KRAS-targeted therapy.

|Jun 02, 2026
The mannosyltransferase DPM1 regulates the activity of ER-stress sensor IRE1 in colorectal cancer.

|Feb 27, 2026
Tumor metabolic adaptation induced by L-asparaginase reveals a vulnerability to PARP1/2 inhibitor in B-cell lymphomas.

Anaïs Aussel, Ivan Nemazanyy, Ashaina Vandenberghe

|Jun 19, 2024
Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma.

Adrien Krug, Rana Mhaidly, Marie Tosolini

|Jun 13, 2024
Immunometabolism unveiled: Pioneering breakthroughs in cancer therapeutics.

Eric Eldering, Jean-Ehrland Ricci

|Feb 07, 2023
IL-7 germline variant: setting the stage for immune-related adverse events.

Hussein Issaoui, Jean-Ehrland Ricci

Pageof 3

Frequent Collaborators

5 joint publications

Sandrine Marchetti

4 joint publications

Johanna Chiche

2 joint publications

Eric Chevet

2 joint publications

Léa Di Mascio